HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Fremes, S. E. Articles by Goldman, B. S. Search for Related Content PubMed PubMed Citation Articles by Fremes, S. E. Articles by Goldman, B. S.

European Journal of Cardio-Thoracic Surgery, Vol 7, 169-180, Copyright © 1993 by European Association for Cardio-thoracic Surgery

ARTICLES

Optimal antithrombotic therapy following aortocoronary bypass: a meta- analysis

SE Fremes, C Levinton, CD Naylor, E Chen, GT Christakis and BS Goldman
Division of Cardiovascular Surgery, Sunnybrook Health Science Center, Toronto, Ontario, Canada.

To evaluate the role of antithrombotic therapy, on preserving graft patency, we performed a meta-analysis of randomized clinical trials involving aspirin (ASA), dipyridamole (D), anticoagulants (AC) and placebo or nontreatment controls (P). Manual literature searches were performed supplemented by computerized MEDLINE listings complete to July 1991. Saphenous vein graft occlusion was determined by angiography (patients with > or = 1 distal anastomotic occlusion). The trial data were aggregated with the methods of Mantel and Haenszel. The results are reported as odds ratios (OR) +/- 95% confidence intervals (CI). Seventeen trials were evaluated. Aspirin strongly influenced graft occlusion [ASA +/- D vs P: OR 0.60, 95% CI 0.51, 0.71, P < 0.0001], but dipyridamole provided no additional benefit [ASA+D vs ASA: OR 0.94, 95% CI 0.72, 1.24, P = 0.71]. Anticoagulants reduced graft occlusion [AC vs P: OR 0.56, 95% CI 0.33, 0.93, P = 0.025] and the results were similar to that achieved with aspirin [ASA vs AC: OR 0.95, 95% CI 0.62, 1.44, P = 0.87]. The combination of aspirin and anticoagulants was superior to anticoagulants alone in two limited trials [ASA+AC vs AC: OR 0.55, 95% CI 0.33, 0.88, P = 0.01]. A low (100 mg) to medium (325 mg) daily aspirin dosage was more effective than a high dose (975 mg). Early postoperative treatment (< or = 6 h) strongly influenced graft occlusion while preoperative administration provided no additional benefit. No mortality advantage was identified for any antithrombotic therapy. Aspirin or anticoagulants enhance saphenous vein graft patency following aortocoronary bypass surgery, and a combination thereof deserves further investigation in a trial large enough to detect the effects of these treatments with respect to clinical events.

This article has been cited by other articles:

				J. Dunning, M. Versteegh, A. Fabbri, A. Pavie, P. Kolh, U. Lockowandt, S. A.M. Nashef, and on behalf of the EACTS Audit and Guidelines Commit Guideline on antiplatelet and anticoagulation management in cardiac surgery. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 73 - 92. [Abstract] [Full Text] [PDF]

				N. Zimmermann, E. Gams, and T. Hohlfeld Aspirin in coronary artery bypass surgery: new aspects of and alternatives for an old antithrombotic agent. Eur. J. Cardiothorac. Surg., July 1, 2008; 34(1): 93 - 108. [Abstract] [Full Text] [PDF]

				N. D. Desai, S. Miwa, D. Kodama, T. Koyama, G. Cohen, M. P. Pelletier, E. A. Cohen, G. T. Christakis, B. S. Goldman, and S. E. Fremes A randomized comparison of intraoperative indocyanine green angiography and transit-time flow measurement to detect technical errors in coronary bypass grafts J. Thorac. Cardiovasc. Surg., September 1, 2006; 132(3): 585 - 594. [Abstract] [Full Text] [PDF]

				N. D. Desai, E. A. Cohen, C. D. Naylor, S. E. Fremes, and the Radial Artery Patency Study Investigators A Randomized Comparison of Radial-Artery and Saphenous-Vein Coronary Bypass Grafts N. Engl. J. Med., November 25, 2004; 351(22): 2302 - 2309. [Abstract] [Full Text] [PDF]

				S. Verma, P. E. Szmitko, R. D. Weisel, D. Bonneau, D. Latter, L. Errett, Y. LeClerc, and S. E. Fremes Should Radial Arteries Be Used Routinely for Coronary Artery Bypass Grafting? Circulation, August 3, 2004; 110(5): e40 - e46. [Full Text] [PDF]

				E. Lim, Z. Ali, A. Ali, T. Routledge, L. Edmonds, D. G Altman, and S. Large Indirect comparison meta-analysis of aspirin therapy after coronary surgery BMJ, December 6, 2003; 327(7427): 1309. [Abstract] [Full Text] [PDF]

				G. Musleh and J. Dunning Does aspirin 6 h after coronary artery bypass grafting optimise graft patency? Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 413 - 415. [Abstract] [Full Text] [PDF]

				J. Dunning and S. Das What is the optimal dose of aspirin after discharge following coronary bypass surgery Interactive CardioVascular and Thoracic Surgery, December 1, 2003; 2(4): 427 - 430. [Abstract] [Full Text] [PDF]

				M J Naik, Y Abu-Omar, A Alvi, N Wright, A Henderson, K Channon, J C Forfar, and D P Taggart Total arterial revascularisation as a primary strategy for coronary artery bypass grafting Postgrad. Med. J., January 1, 2003; 79(927): 43 - 48. [Abstract] [Full Text] [PDF]

				D. F. Del Rizzo, M. C. Moon, J. P. Werner, and P. Zahradka A novel organ culture method to study intimal hyperplasia at the site of a coronary artery bypass anastomosis Ann. Thorac. Surg., April 1, 2001; 71(4): 1273 - 1279. [Abstract] [Full Text] [PDF]

				G. Cohen, M. G. Tamariz, J. Y. Sever, N. Liaghati, V. Guru, G. T. Christakis, G. Bhatnagar, C. Cutrara, L. Abouzahr, B. S. Goldman, et al. The radial artery versus the saphenous vein graft in contemporary CABG: a case-matched study Ann. Thorac. Surg., January 1, 2001; 71(1): 180 - 186. [Abstract] [Full Text] [PDF]

				K. M. Southgate, D. Mehta, M. B. Izzat, A. C. Newby, and G. D. Angelini Increased Secretion of Basement Membrane–Degrading Metalloproteinases in Pig Saphenous Vein Into Carotid Artery Interposition Grafts Arterioscler. Thromb. Vasc. Biol., July 1, 1999; 19(7): 1640 - 1649. [Abstract] [Full Text] [PDF]

				G. Cohen, J. Ivanov, R. D. Weisel, V. Rao, M. K. Mohabeer, and D. A. G. Mickle Aprotinin and Dipyridamole for the Safe Reduction of Postoperative Blood Loss Ann. Thorac. Surg., March 1, 1998; 65(3): 674 - 683. [Abstract] [Full Text] [PDF]

				V. Fuster and D. A. Vorchheimer Prevention of Atherosclerosis in Coronary-Artery Bypass Grafts N. Engl. J. Med., January 16, 1997; 336(3): 212 - 213. [Full Text]